Clinical Study to Evaluate the Efficacy of HUDC_VT in Patients With Bacterial Vaginosis
Status:
Unknown status
Trial end date:
2018-03-30
Target enrollment:
Participant gender:
Summary
The objective of the study is to confirm the pharmacological mechanism and evaluate the
efficacy and safety after HUDC-VT administration compared to placebo in patients with
bacterial vaginosis.
Vaginitis in adult women is extremely common and it often results in marked suffering.
Epidemiologic studies indicate the high prevalence of vaginitis and the large number of
causes in US.
The broad-spectrum antibiotics such as metronidazole have been used as a treatment of
vaginitis.However, it is not desirable using of these antibiotics caused appearance of
resistant bacterium and killing normal bacterium including lactobacillus.
In addition, it has been reported that long term treatment of antibiotics can be caused body
toxicity through absolution by vagina.
The product, HUDC_VT, is a effective and safe vaginal tablet composed glucose and sodium
chloride for treatment of vaginitis by preserving healthy condition in vagina.